05/16/2024
12:49 PM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 424B3 | |
05/07/2024
9:24 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
04/16/2024
4:27 PM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
03/12/2024
3:17 PM | Scinai Immunotherapeutics Ltd. (Subject)
Scinai Immunotherapeutics (Subject)
STONE DANIEL E. (Filed by)
| Form SC 13D | |
01/30/2024
3:19 PM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
01/24/2024
1:33 PM | Scinai Immunotherapeutics Ltd. (Subject)
Scinai Immunotherapeutics (Subject)
STONE DANIEL E. (Filed by)
| Form SC 13G/A | |
01/18/2024
10:50 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
|
01/12/2024
6:32 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
01/09/2024
7:45 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024
3:54 PM | SABBY MANAGEMENT, LLC (Filed by)
Scinai Immunotherapeutics Ltd. (Subject)
Scinai Immunotherapeutics (Subject)
| Form SC 13G/A | |
01/02/2024
8:57 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 424B3 | |
01/02/2024
8:58 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 424B3 | |
01/02/2024
8:24 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024
8:26 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
01/02/2024
7:24 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 424B3 | |
12/26/2023
11:15 PM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form EFFECT | |
12/22/2023
8:11 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form F-1/A | |
12/14/2023
5:21 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/20/2023
9:49 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/13/2023
7:25 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/07/2023
5:09 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/03/2023
7:49 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
11/02/2023
12:21 PM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
10/03/2023
11:38 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form D
Notice of Exempt Offering of Securities | |
09/22/2023
3:16 PM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/20/2023
5:08 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2023
2:06 PM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/19/2023
9:03 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 424B5 | |
09/11/2023
8:30 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/07/2023
4:27 PM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 424B3 | |
09/06/2023
11:01 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
09/06/2023
10:44 AM | Scinai Immunotherapeutics Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/27/2023
11:15 PM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form EFFECT | |
08/23/2023
5:10 AM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/18/2023
3:16 PM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form F-3
Registration statement for securities of certain foreign private issuers | |
08/18/2023
9:07 AM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K/A | |
08/14/2023
5:08 AM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K/A | |
08/11/2023
8:44 AM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
08/01/2023
3:00 PM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/12/2023
2:10 PM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/05/2023
8:28 AM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
Trump Reveals Conspiracy Behind Fed-Controlled Digital Currency. (Ad) Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs).
If these plans are implemented, it could mean the end of America as we know it. This means you must act NOW before it's too late. |
07/05/2023
8:17 AM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023
3:05 PM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
07/03/2023
3:10 PM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 6-K
Report of foreign private issuer pursuant to Rule 13a-16 or 15d-16 under the Securities Exchange Act of 1934 | |
06/08/2023
3:30 PM | BiondVax Pharmaceuticals Ltd. (Filer)
Scinai Immunotherapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
